CPLX4
Complexin-4
Also known as: CPLX4_HUMAN, CPX-IV
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z7G2
- Gene
- CPLX4
- Ensembl
- ENSG00000166569
- Chromosome
- 18
- Canonical length
- 160 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene likely encodes a member of the complexin family. The encoded protein may be involved in synaptic vesicle exocytosis. [provided by RefSeq, Jan 2009]
Canonical amino-acid sequenceUniProt
160 residues, UniProt reviewed canonical sequence.
>Q7Z7G2|CPLX4
1 MAFLMKSMIS NQVKNLGFGG GSEENKEEGG ASDPAAAQGM TREEYEEYQK QMIEEKMERD
61 AAFTQKKAER ACLRVHLREK YRLPKSEMDE NQIQMAGDDV DLPEDLRKMV DEDQEEEEDK
121 DSILGQIQNL QNMDLDTIKE KAQATFTEIK QTAEQKCSVMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CPLX4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 292 nTPM
Expression across tissuesHPA
Tissue
- retina: 292 nTPM
- choroid plexus: 3.2 nTPM
- cerebellum: 1.3 nTPM
- testis: 0.1 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
Single-cell type
- rod photoreceptor cells: 283 nCPM
- cone photoreceptor cells: 248 nCPM
- retinal bipolar cells: 92 nCPM
- müller glia: 15 nCPM
- retinal horizontal cells: 10 nCPM
- retinal pigment epithelial cells: 8.5 nCPM
Immune cell
- neutrophil: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebellum: 2.7 nTPM
- hypothalamus: 1.8 nTPM
- choroid plexus: 1.7 nTPM
- cerebral cortex: 0.9 nTPM
- white matter: 0.7 nTPM
- amygdala: 0.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.71
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.06
- DepMap mean gene effect
- 0.26
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- modulation of chemical synaptic transmission
- regulation of neurotransmitter secretion
- regulation of synaptic vesicle fusion to presynaptic active zone membrane
- synaptic vesicle exocytosis
- visual perception
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CPLX4 as an antibody target. Whether an autoantibody or antibody against CPLX4 could matter depends on whether native CPLX4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CPLX4 is annotated at the cell surface, where native CPLX4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CPLX4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...